Introduction

The Fibromyalgia Impact Questionnaire (FIQ-10) is a brief self-report instrument designed to assess the overall impact of fibromyalgia on health status, functional ability, and quality of life. Derived from the original Fibromyalgia Impact Questionnaire (FIQ), the 10-item version provides a rapid yet comprehensive assessment of the physical, emotional, and social consequences of fibromyalgia. It is widely used in rheumatology, pain medicine, rehabilitation, and clinical research to evaluate disease burden and monitor treatment outcomes.

Description

The FIQ-10 consists of 10 items that evaluate the major domains affected by fibromyalgia, including:

  • Physical functioning.
  • Pain intensity.
  • Fatigue.
  • Morning tiredness.
  • Sleep quality.
  • Stiffness.
  • Anxiety.
  • Depression.
  • Ability to perform daily activities.
  • Overall disease impact.

Items are rated using Likert-type or visual analogue scales (VAS), with higher scores indicating greater symptom severity and functional impairment.

Purpose

The FIQ-10 is designed to:

  • Assess the impact of fibromyalgia on daily life.
  • Measure symptom severity and functional limitations.
  • Evaluate health-related quality of life.
  • Monitor clinical progress and treatment response.
  • Support clinical trials and epidemiological research.

Administration

The questionnaire is self-administered and generally requires 5–10 minutes to complete. It is intended for adults diagnosed with fibromyalgia and is suitable for use in rheumatology clinics, pain management centers, rehabilitation programs, and research studies.

Scoring

Each item is scored according to standardized procedures, and individual scores are summed or transformed into a total impact score. Higher scores indicate:

  • Greater symptom burden.
  • Increased physical disability.
  • Poorer emotional well-being.
  • Reduced health-related quality of life.

Lower scores reflect better functional status and less severe disease impact.

Interpretation

Higher FIQ-10 scores indicate that fibromyalgia substantially interferes with daily functioning, occupational performance, physical activity, and psychological well-being. Elevated scores are often associated with increased pain severity, fatigue, sleep disturbances, anxiety, and depression. Lower scores suggest better symptom control and improved quality of life. Interpretation should always be considered alongside clinical examination and complementary patient-reported outcome measures.

Statistical Analysis

Psychometric evaluation of the FIQ-10 commonly includes:

  • Descriptive statistics.
  • Internal consistency (Cronbach’s alpha).
  • McDonald’s Omega.
  • Test–retest reliability.
  • Exploratory and Confirmatory Factor Analysis (EFA/CFA).
  • Item-total correlations.
  • Convergent and discriminant validity.
  • Correlation and multiple regression analyses.
  • Responsiveness to clinical change.
  • Group comparisons (t-test, ANOVA, ANCOVA).
  • Receiver Operating Characteristic (ROC) analysis when evaluating diagnostic or clinical cut-off values.

Studies have demonstrated good reliability, validity, and responsiveness, making the FIQ-10 an effective tool for both clinical practice and longitudinal research.

Applications

The FIQ-10 is widely used in:

  • Rheumatology.
  • Pain medicine.
  • Rehabilitation medicine.
  • Clinical psychology.
  • Primary healthcare.
  • Clinical trials.
  • Quality-of-life research.
  • Outcome evaluation of pharmacological and non-pharmacological interventions.

Advantages

  • Brief and easy to administer.
  • Comprehensive assessment of fibromyalgia-related health status.
  • Sensitive to changes following treatment.
  • Suitable for routine clinical monitoring.
  • Strong psychometric properties across diverse patient populations.

Limitations

As a self-report instrument, the FIQ-10 may be influenced by current mood, pain perception, fatigue, and individual response styles. It measures perceived disease impact rather than objective physical performance, and results should therefore be interpreted together with clinical findings and complementary assessments of pain, physical function, and psychological well-being.

References

Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and Validation.

Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L. (2009). The Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and Psychometric Properties.

Salaffi, F., Sarzi-Puttini, P., Ciapetti, A., & Atzeni, F. (2009). Assessment Instruments for Patients with Fibromyalgia: Properties, Applications and Interpretation.

Mease, P. (2009). Fibromyalgia Syndrome: Review of Clinical Presentation, Pathogenesis, Outcome Measures, and Treatment.